Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
暂无分享,去创建一个
D. Galanaud | N. Weiss | S. Demeret | A. Idbaih | B. Eymard | V. Leblond | C. Deback | C. Houillier | D. Saadoun | N. Shor | A. Bellanger | M. Uzunov | A. Guihot | V. Pourcher | D. Roos-Weil
[1] S. Demeret,et al. Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab , 2019, British journal of haematology.
[2] C. Mengelle,et al. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy , 2019, Emerging infectious diseases.
[3] A. Straube,et al. Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency , 2019, Neurology: Neuroimmunology & Neuroinflammation.
[4] Bryan R. Smith,et al. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy , 2019, The New England journal of medicine.
[5] C. Mengelle,et al. Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab. , 2019, The New England journal of medicine.
[6] A. Paetau,et al. The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based Study , 2019, Open forum infectious diseases.
[7] A. Verma,et al. Characteristics and outcomes of progressive multifocal leukoencephalopathy in hematologic malignancies and stem cell transplant – a case series , 2018, Leukemia & lymphoma.
[8] J. Ramon,et al. Authors and Affiliations , 2014 .
[9] J. Sejvar,et al. PML diagnostic criteria , 2013, Neurology.
[10] David Green,et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. , 2009, Blood.
[11] G. Freeman,et al. Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.